1. Home
  2. PRQR vs CIK Comparison

PRQR vs CIK Comparison

Compare PRQR & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • CIK
  • Stock Information
  • Founded
  • PRQR 2012
  • CIK 1987
  • Country
  • PRQR Netherlands
  • CIK United States
  • Employees
  • PRQR N/A
  • CIK N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • CIK Finance/Investors Services
  • Sector
  • PRQR Health Care
  • CIK Finance
  • Exchange
  • PRQR Nasdaq
  • CIK Nasdaq
  • Market Cap
  • PRQR 179.1M
  • CIK 154.6M
  • IPO Year
  • PRQR 2014
  • CIK N/A
  • Fundamental
  • Price
  • PRQR $2.30
  • CIK $2.97
  • Analyst Decision
  • PRQR Strong Buy
  • CIK
  • Analyst Count
  • PRQR 8
  • CIK 0
  • Target Price
  • PRQR $8.88
  • CIK N/A
  • AVG Volume (30 Days)
  • PRQR 356.8K
  • CIK 115.4K
  • Earning Date
  • PRQR 08-07-2025
  • CIK 01-01-0001
  • Dividend Yield
  • PRQR N/A
  • CIK 9.03%
  • EPS Growth
  • PRQR N/A
  • CIK N/A
  • EPS
  • PRQR N/A
  • CIK N/A
  • Revenue
  • PRQR $21,212,711.00
  • CIK N/A
  • Revenue This Year
  • PRQR N/A
  • CIK N/A
  • Revenue Next Year
  • PRQR N/A
  • CIK N/A
  • P/E Ratio
  • PRQR N/A
  • CIK N/A
  • Revenue Growth
  • PRQR 85.91
  • CIK N/A
  • 52 Week Low
  • PRQR $1.07
  • CIK $2.50
  • 52 Week High
  • PRQR $4.62
  • CIK $3.19
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 68.07
  • CIK 66.91
  • Support Level
  • PRQR $2.10
  • CIK $2.96
  • Resistance Level
  • PRQR $2.18
  • CIK $2.92
  • Average True Range (ATR)
  • PRQR 0.13
  • CIK 0.03
  • MACD
  • PRQR 0.01
  • CIK 0.01
  • Stochastic Oscillator
  • PRQR 54.55
  • CIK 93.29

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

Share on Social Networks: